Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Treatment of Peyronie's disease with oral pentoxifylline

Abstract

Background A 51-year-old male presented with a penile deformity without obvious etiology. Physical examination revealed hard plaques in the dorsal and ventral penis.

Investigations Physical examination, penile ultrasound.

Diagnosis Peyronie's disease.

Management Oral pentoxifylline.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Penile ultrasound showing areas of calcification within the plaques at the time of presentation.
Figure 2: Penile ultrasound showing areas of calcification within the plaques at the time of presentation (different cross-section from Figure 1).
Figure 3: Penile ultrasound showing resolution of the calcification within the dorsal plaque after 2 years of pentoxifylline treatment.

References

  1. Schwarzer U et al. (2001) The prevalence of Peyronie's disease: results of a large survey. BJU Int 88: 727–730

    Article  CAS  Google Scholar 

  2. Mulhall JP et al. (2004) Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 171: 2350–2353

    Article  Google Scholar 

  3. Gholami SS et al. (2002) Peyronie's disease: a review. J Urol 169: 1234–1241

    Article  Google Scholar 

  4. Williams JL and Thomas GG (1970) The natural history of Peyronie's disease. J Urol 103: 75–76

    Article  CAS  Google Scholar 

  5. Gelbard MK et al. (1990) The natural history of Peyronie's disease. J Urol 144: 1376–1379

    Article  CAS  Google Scholar 

  6. Zargooshi J (2004) Trauma as the cause of Peyronie's disease: penile fracture as a model of trauma. J Urol 172: 186–188

    Article  Google Scholar 

  7. Levine LA and Greenfield JM (2003) Establishing a standardized evaluation of the man with Peyronie's disease. Int J Impot Res 15 (Suppl): S103–S112

    Article  Google Scholar 

  8. Hauck EW et al. (2003) Diagnostic value of magnetic resonance imaging in Peyronie's disease: a comparison both with palpation and ultrasound in the evaluation of plaque formation. Eur Urol 43: 293–300

    Article  Google Scholar 

  9. Chiao TB and Lee AJ (2005) Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis. Ann Pharmacother 39: 516–522

    Article  CAS  Google Scholar 

  10. Delanian S et al. (2005) Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 22: 1–10

    Google Scholar 

  11. Haddad P et al. (2005) Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: a phase II clinical trial. Radiother Oncol 77: 324–326

    Article  CAS  Google Scholar 

  12. Hille A et al. (2005) Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181: 606–614

    Article  Google Scholar 

  13. Adams LA et al. (2004) A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol 99: 2365–2368

    Article  CAS  Google Scholar 

  14. Georges C et al. (2004) Case report: resolution of symptomatic epidural fibrosis following treatment with combined pentoxifylline–tocopherol. Br J Radiol 77: 885–887

    Article  CAS  Google Scholar 

  15. Delanian S and Lefaix JL (2002) Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate. Br J Radiol 75: 467–469

    Article  CAS  Google Scholar 

  16. Valente EG et al. (2003) L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide 9: 229–244

    Article  CAS  Google Scholar 

  17. Videla S et al. Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis. J Pharmacol Exp Ther, in press

  18. Gumus B et al. (2004) Histopathological effects of sildenafil citrate on rat corpus cavernosum. Acta Histochem 106: 37–45

    Article  CAS  Google Scholar 

  19. Schwartz EJ et al. (2004) Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 171: 771–774

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tom F Lue.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brant, W., Dean, R. & Lue, T. Treatment of Peyronie's disease with oral pentoxifylline. Nat Rev Urol 3, 111–115 (2006). https://doi.org/10.1038/ncpuro0409

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0409

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing